Tapewire

Nasdaq · USD

CPIX

CUMBERLAND PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
6757
SEC CIK
0001087294
Parsed reports
362

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 31, 2022 Filed Nov 18, 2022 22:16 UTC PurchaseCommon Stock 105 $2.54 $266.70
Disclosure

SEC source: 0001209191-22-057939 · doc4.xml · nonDerivative · entry 25

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199,700

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 28, 2022 Filed Nov 18, 2022 22:23 UTC PurchaseCommon Stock 20 $2.52 $50.40
Disclosure

SEC source: 0001209191-22-057947 · doc4.xml · nonDerivative · entry 24

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,768

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 28, 2022 Filed Nov 18, 2022 22:21 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.52 $78.12
Disclosure

SEC source: 0001209191-22-057945 · doc4.xml · nonDerivative · entry 24

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,944

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 28, 2022 Filed Nov 18, 2022 22:17 UTC PurchaseCommon Stock 65 $2.52 $163.80
Disclosure

SEC source: 0001209191-22-057942 · doc4.xml · nonDerivative · entry 24

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,376

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 28, 2022 Filed Nov 18, 2022 22:16 UTC PurchaseCommon Stock 105 $2.52 $264.60
Disclosure

SEC source: 0001209191-22-057939 · doc4.xml · nonDerivative · entry 24

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199,595

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 27, 2022 Filed Nov 18, 2022 22:23 UTC PurchaseCommon Stock 20 $2.49 $49.80
Disclosure

SEC source: 0001209191-22-057947 · doc4.xml · nonDerivative · entry 23

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,748

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 27, 2022 Filed Nov 18, 2022 22:21 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.49 $77.19
Disclosure

SEC source: 0001209191-22-057945 · doc4.xml · nonDerivative · entry 23

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,913

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 27, 2022 Filed Nov 18, 2022 22:17 UTC PurchaseCommon Stock 65 $2.49 $161.85
Disclosure

SEC source: 0001209191-22-057942 · doc4.xml · nonDerivative · entry 23

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,311

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 27, 2022 Filed Nov 18, 2022 22:16 UTC PurchaseCommon Stock 105 $2.49 $261.45
Disclosure

SEC source: 0001209191-22-057939 · doc4.xml · nonDerivative · entry 23

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199,490

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 26, 2022 Filed Nov 18, 2022 22:23 UTC PurchaseCommon Stock 20 $2.42 $48.40
Disclosure

SEC source: 0001209191-22-057947 · doc4.xml · nonDerivative · entry 22

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,728

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 26, 2022 Filed Nov 18, 2022 22:21 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.42 $75.02
Disclosure

SEC source: 0001209191-22-057945 · doc4.xml · nonDerivative · entry 22

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,882

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 26, 2022 Filed Nov 18, 2022 22:17 UTC PurchaseCommon Stock 65 $2.42 $157.30
Disclosure

SEC source: 0001209191-22-057942 · doc4.xml · nonDerivative · entry 22

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,246

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 26, 2022 Filed Nov 18, 2022 22:16 UTC PurchaseCommon Stock 105 $2.42 $254.10
Disclosure

SEC source: 0001209191-22-057939 · doc4.xml · nonDerivative · entry 22

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199,385

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 25, 2022 Filed Nov 18, 2022 22:23 UTC PurchaseCommon Stock 20 $2.44 $48.80
Disclosure

SEC source: 0001209191-22-057947 · doc4.xml · nonDerivative · entry 21

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,708

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 25, 2022 Filed Nov 18, 2022 22:21 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.44 $75.64
Disclosure

SEC source: 0001209191-22-057945 · doc4.xml · nonDerivative · entry 21

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,851

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 25, 2022 Filed Nov 18, 2022 22:17 UTC PurchaseCommon Stock 65 $2.44 $158.60
Disclosure

SEC source: 0001209191-22-057942 · doc4.xml · nonDerivative · entry 21

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,181

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 25, 2022 Filed Nov 18, 2022 22:16 UTC PurchaseCommon Stock 105 $2.44 $256.20
Disclosure

SEC source: 0001209191-22-057939 · doc4.xml · nonDerivative · entry 21

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199,280

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 24, 2022 Filed Nov 18, 2022 22:23 UTC PurchaseCommon Stock 20 $2.38 $47.60
Disclosure

SEC source: 0001209191-22-057947 · doc4.xml · nonDerivative · entry 20

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,688

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 24, 2022 Filed Nov 18, 2022 22:21 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.38 $73.78
Disclosure

SEC source: 0001209191-22-057945 · doc4.xml · nonDerivative · entry 20

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,820

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 24, 2022 Filed Nov 18, 2022 22:17 UTC PurchaseCommon Stock 65 $2.38 $154.70
Disclosure

SEC source: 0001209191-22-057942 · doc4.xml · nonDerivative · entry 20

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,116

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 24, 2022 Filed Nov 18, 2022 22:16 UTC PurchaseCommon Stock 105 $2.38 $249.90
Disclosure

SEC source: 0001209191-22-057939 · doc4.xml · nonDerivative · entry 20

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199,175

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 21, 2022 Filed Nov 18, 2022 22:23 UTC PurchaseCommon Stock 20 $2.49 $49.80
Disclosure

SEC source: 0001209191-22-057947 · doc4.xml · nonDerivative · entry 19

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,668

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 21, 2022 Filed Nov 18, 2022 22:21 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.49 $77.19
Disclosure

SEC source: 0001209191-22-057945 · doc4.xml · nonDerivative · entry 19

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,789

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 21, 2022 Filed Nov 18, 2022 22:17 UTC PurchaseCommon Stock 65 $2.49 $161.85
Disclosure

SEC source: 0001209191-22-057942 · doc4.xml · nonDerivative · entry 19

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,051

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 21, 2022 Filed Nov 18, 2022 22:16 UTC PurchaseCommon Stock 105 $2.49 $261.45
Disclosure

SEC source: 0001209191-22-057939 · doc4.xml · nonDerivative · entry 19

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199,070

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 20, 2022 Filed Nov 18, 2022 22:23 UTC PurchaseCommon Stock 20 $2.44 $48.80
Disclosure

SEC source: 0001209191-22-057947 · doc4.xml · nonDerivative · entry 18

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,648

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 20, 2022 Filed Nov 18, 2022 22:21 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.44 $75.64
Disclosure

SEC source: 0001209191-22-057945 · doc4.xml · nonDerivative · entry 18

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,758

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 20, 2022 Filed Nov 18, 2022 22:17 UTC PurchaseCommon Stock 65 $2.44 $158.60
Disclosure

SEC source: 0001209191-22-057942 · doc4.xml · nonDerivative · entry 18

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,986

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 20, 2022 Filed Nov 18, 2022 22:16 UTC PurchaseCommon Stock 105 $2.44 $256.20
Disclosure

SEC source: 0001209191-22-057939 · doc4.xml · nonDerivative · entry 18

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,965

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 19, 2022 Filed Nov 18, 2022 22:23 UTC PurchaseCommon Stock 20 $2.42 $48.40
Disclosure

SEC source: 0001209191-22-057947 · doc4.xml · nonDerivative · entry 17

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,628

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 19, 2022 Filed Nov 18, 2022 22:21 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.42 $75.02
Disclosure

SEC source: 0001209191-22-057945 · doc4.xml · nonDerivative · entry 17

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,727

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 19, 2022 Filed Nov 18, 2022 22:17 UTC PurchaseCommon Stock 65 $2.42 $157.30
Disclosure

SEC source: 0001209191-22-057942 · doc4.xml · nonDerivative · entry 17

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,921

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 19, 2022 Filed Nov 18, 2022 22:16 UTC PurchaseCommon Stock 105 $2.42 $254.10
Disclosure

SEC source: 0001209191-22-057939 · doc4.xml · nonDerivative · entry 17

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,860

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 18, 2022 Filed Nov 18, 2022 22:23 UTC PurchaseCommon Stock 20 $2.46 $49.20
Disclosure

SEC source: 0001209191-22-057947 · doc4.xml · nonDerivative · entry 16

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,608

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 18, 2022 Filed Nov 18, 2022 22:21 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.46 $76.26
Disclosure

SEC source: 0001209191-22-057945 · doc4.xml · nonDerivative · entry 16

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,696

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 18, 2022 Filed Nov 18, 2022 22:17 UTC PurchaseCommon Stock 65 $2.46 $159.90
Disclosure

SEC source: 0001209191-22-057942 · doc4.xml · nonDerivative · entry 16

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,856

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 18, 2022 Filed Nov 18, 2022 22:16 UTC PurchaseCommon Stock 105 $2.46 $258.30
Disclosure

SEC source: 0001209191-22-057939 · doc4.xml · nonDerivative · entry 16

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,755

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 17, 2022 Filed Nov 18, 2022 22:23 UTC PurchaseCommon Stock 20 $2.33 $46.60
Disclosure

SEC source: 0001209191-22-057947 · doc4.xml · nonDerivative · entry 15

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,588

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 17, 2022 Filed Nov 18, 2022 22:21 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.33 $72.23
Disclosure

SEC source: 0001209191-22-057945 · doc4.xml · nonDerivative · entry 15

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,665

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 17, 2022 Filed Nov 18, 2022 22:17 UTC PurchaseCommon Stock 65 $2.33 $151.45
Disclosure

SEC source: 0001209191-22-057942 · doc4.xml · nonDerivative · entry 15

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,791

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 17, 2022 Filed Nov 18, 2022 22:16 UTC PurchaseCommon Stock 105 $2.33 $244.65
Disclosure

SEC source: 0001209191-22-057939 · doc4.xml · nonDerivative · entry 15

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,650

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 14, 2022 Filed Nov 18, 2022 22:23 UTC PurchaseCommon Stock 20 $2.31 $46.20
Disclosure

SEC source: 0001209191-22-057947 · doc4.xml · nonDerivative · entry 14

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,568

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 14, 2022 Filed Nov 18, 2022 22:21 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.31 $71.61
Disclosure

SEC source: 0001209191-22-057945 · doc4.xml · nonDerivative · entry 14

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,634

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 14, 2022 Filed Nov 18, 2022 22:17 UTC PurchaseCommon Stock 65 $2.31 $150.15
Disclosure

SEC source: 0001209191-22-057942 · doc4.xml · nonDerivative · entry 14

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,726

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 14, 2022 Filed Nov 18, 2022 22:16 UTC PurchaseCommon Stock 105 $2.31 $242.55
Disclosure

SEC source: 0001209191-22-057939 · doc4.xml · nonDerivative · entry 14

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,545

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 13, 2022 Filed Nov 18, 2022 22:23 UTC PurchaseCommon Stock 20 $2.38 $47.60
Disclosure

SEC source: 0001209191-22-057947 · doc4.xml · nonDerivative · entry 13

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,548

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 13, 2022 Filed Nov 18, 2022 22:21 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.38 $73.78
Disclosure

SEC source: 0001209191-22-057945 · doc4.xml · nonDerivative · entry 13

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,603

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 13, 2022 Filed Nov 18, 2022 22:17 UTC PurchaseCommon Stock 65 $2.38 $154.70
Disclosure

SEC source: 0001209191-22-057942 · doc4.xml · nonDerivative · entry 13

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,661

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 13, 2022 Filed Nov 18, 2022 22:16 UTC PurchaseCommon Stock 105 $2.38 $249.90
Disclosure

SEC source: 0001209191-22-057939 · doc4.xml · nonDerivative · entry 13

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,440

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 12, 2022 Filed Nov 18, 2022 22:23 UTC PurchaseCommon Stock 20 $2.49 $49.80
Disclosure

SEC source: 0001209191-22-057947 · doc4.xml · nonDerivative · entry 12

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,528

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.